Načítá se...
HER2/neu Immunostaining in Invasive Breast Cancer: Analysis of False Positive Factors
OBJECTIVES: HER2/neu gene amplification by Fluorescent in situ hybridization and protein expression by immunohistochemistry have been used for prognosis and guidance for the treatment of invasive ductal carcinoma of the breast with Trastuzumab. False positive results are a significant problem where...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
OMJ
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3191663/ https://ncbi.nlm.nih.gov/pubmed/22043354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2010.78 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|